Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
1988.
Rabies Vaccine Failures.
The Lancet,
Vol. 331,
Issue. 8591,
p.
917.
Barth, R.
Franke, V.
Müller, H.
and
Weinmann, E.
1990.
Purified chick-embryo-cell (PCEC) rabies vaccine: its potency performance in different test systems and in humans.
Vaccine,
Vol. 8,
Issue. 1,
p.
41.
Hatchett, Richard P.
1991.
Rabies: the disease and the value of intensive care treatment.
Intensive Care Nursing,
Vol. 7,
Issue. 1,
p.
53.
1993.
Question and Answer.
Tropical Doctor,
Vol. 23,
Issue. 2,
p.
95.
Meslin, F.-X.
Fishbein, D. B.
and
Matter, H. C.
1994.
Lyssaviruses.
Vol. 187,
Issue. ,
p.
1.
Haupt, Wolfgang
1999.
Rabies – risk of exposure and current trends in prevention of human cases.
Vaccine,
Vol. 17,
Issue. 13-14,
p.
1742.
Warrell, M. J.
and
Warrell, D. A.
2000.
Intradermal Postexposure Rabies Vaccine Regimens.
Clinical Infectious Diseases,
Vol. 31,
Issue. 3,
p.
844.
Chotwiwatthanakun, Charoonroj
Pratanaphon, Ronachai
Akesowan, Surasak
Sriprapat, Supod
and
Ratanabanangkoon, Kavi
2001.
Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol.
Toxicon,
Vol. 39,
Issue. 10,
p.
1487.
Wilde, Henry
Khawplod, Pakamatz
Hemachudha, Thiravat
and
Sitprija, Visith
2002.
Postexposure Treatment of Rabies Infection: Can It Be Done without Immunoglobulin?.
Clinical Infectious Diseases,
Vol. 34,
Issue. 4,
p.
477.
Warrell, M. J.
and
Warrell, D. A.
2002.
Intradermal Regimens for Rabies Postexposure Prophylaxis: More Confusion.
Clinical Infectious Diseases,
Vol. 35,
Issue. 2,
p.
213.
Wilde, Henry
Khawplod, Pakamatz
Hemachudha, Thiravat
and
Sitprija, Visith
2002.
Reply.
Clinical Infectious Diseases,
Vol. 35,
Issue. 2,
p.
215.
Sriprapat, Supod
Aeksowan, Surasak
Sapsutthipas, Sompong
Chotwiwatthanakun, Charoonroj
Suttijitpaisal, Porntip
Pratanaphon, Ronachai
Khow, Orawan
Sitprija, Visith
and
Ratanabanangkoon, Kavi
2003.
The impact of a low dose, low volume, multi-site immunization on the production of therapeutic antivenoms in Thailand.
Toxicon,
Vol. 41,
Issue. 1,
p.
57.
Kamoltham, Thavatchai
Wilde, Henry
and
Hemachudha, Thiravat
2003.
Letter to the Editor.
Vaccine,
Vol. 21,
Issue. 21-22,
p.
2691.
Warrell, Mary
and
Warrell, David
2004.
Rabies and other lyssavirus diseases.
The Lancet,
Vol. 363,
Issue. 9424,
p.
1907.
Warrell, Mary J.
Riddell, Anna
Yu, Ly-Mee
Phipps, Judith
Diggle, Linda
Bourhy, Hervé
Deeks, Jonathan J.
Fooks, Anthony R.
Audry, Laurent
Brookes, Sharon M.
Meslin, François-Xavier
Moxon, Richard
Pollard, Andrew J.
Warrell, David A.
and
Hotez, Peter J.
2008.
A Simplified 4-Site Economical Intradermal Post-Exposure Rabies Vaccine Regimen: A Randomised Controlled Comparison with Standard Methods.
PLoS Neglected Tropical Diseases,
Vol. 2,
Issue. 4,
p.
e224.
McGettigan, James P
2010.
Experimental rabies vaccines for humans.
Expert Review of Vaccines,
Vol. 9,
Issue. 10,
p.
1177.
Warrell, Mary
2010.
Rabies and African bat lyssavirus encephalitis and its prevention.
International Journal of Antimicrobial Agents,
Vol. 36,
Issue. ,
p.
S47.
Warrell, M. J.
2011.
Intradermal Immunization.
Vol. 351,
Issue. ,
p.
139.
Warrell, M.J.
2012.
Current rabies vaccines and prophylaxis schedules: Preventing rabies before and after exposure.
Travel Medicine and Infectious Disease,
Vol. 10,
Issue. 1,
p.
1.
Permpalung, Nitipong
Wongrakpanich, Supakanya
Korpaisarn, Sira
Tanratana, Pansakorn
and
Angsanakul, Jaruboot
2013.
Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization.
Vaccine,
Vol. 31,
Issue. 38,
p.
4079.